Partner With Us NRI

Vijaya Diagnostic Centre Ltd share Price

Company details

6M Return 26.87%
1Y Return 15.42%
Mkt Cap.(Cr) 5,105.85
Volume 48,592
Div Yield 0.20%
OI Chg %
Volume 48,592

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Healthcare Services company Vijaya Diagnostic Centre announced Q4FY23 & FY23 results:

  • Q4FY23:
    • Revenue from Operations increased by 4.1% YoY to Rs 1,210 million, Non-Covid Revenues grew by 22.4% YoY
      • The Non-COVID growth was driven by both radiology and pathology segments, highlighting the strength of our integrated model.
      • During Q4FY23, the Non-COVID business comprised 99% of the total revenue share as against 85% of revenue share in Q4FY22
      • Wellness share in Q4FY23 was up at 13.4% as against 8.4% in Q4FY22
      • Revenue composition from the B2C segment stood at 94.8%
    • EBITDA stood at Rs 491 million. EBITDA margin for the quarter was 40.6% as against 41.2% in Q4FY22
    • PAT stood at Rs 275 million. translating into a PAT margin of 22.7%
  • FY23:
    • Revenue from Operations stood at Rs 4,592 million as against Rs 4,624 million in FY22, NonCovid Revenues grew by 14.7% YoY
      • Wellness share in FY23 was up at 12.1% as against 6.8% in FY22
      • Revenue composition from the B2C segment continued to stay strong at 95%
    • EBITDA stood at Rs 1,820 million. EBITDA margin for FY23 was 39.6%
    • PAT stood at Rs 846 million. translating into a PAT margin of 18.4% in FY23

Commenting on the performance Suprita Reddy, CEO said, "We are extremely delighted to announce that Q4 witnessed the stellar performance, with the achievement of the highest ever quarterly Non-COVID revenue growth of 22.4% year-on-year. This was characterised by strong performance in both radiology and pathology segments, reinforcing the strength of our integrated model.

We consistently maintained our expansion momentum this quarter, expanding by 2 new hubs, 1 spoke and 2 mini spokes, taking the total centre count to 121. A noteworthy achievement during the quarter was the successful inauguration of VDCL’s state-of-the-art facility in Tirupati, Andhra Pradesh. Despite it being a relatively new location, we are glad to share that the customer response and the acceptance of our brand have been phenomenal.

It is a thing of great joy and pride that our Rajahmundry and Punjagutta hubs have demonstrated consistent performance amidst immense competition in the diagnostic space and achieved an operating break-even within an extremely short span of just two to three quarters from the commencement of operations.

The recently implemented comprehensive LIMS has successfully stabilized and is being effortlessly used across all our centres. This marks the fulfilment of a crucial milestone, enabling us to streamline operations and enhance efficiency on a larger scale, across our vast network of centres.

Taking progressively steady strides towards patient convenience and a holistic patient experience, we have successfully built and launched a robust and easy-to-use mobile app that significantly enhances the overall patient experience. It is available for all test types, both in radiology and pathology alike, making it one-of-a-kind in the diagnostic space. This all-encompassing app is available for both iOS & Android. The company has also completed the successful roll-out of a fully functional e-commerce website.

Our informed strategy of digital transformation, market research-backed approach for new market expansion and concentration on the enhancement of our network of centres will ensure sustainable year-on-year growth. We aim to adopt the highest standards of quality and to deliver a holistic customer experience whilst employing the most advanced technology and we firmly believe that this will enable us to make the most of the ever-evolving opportunity for growth in the diagnostic space."



Result PDF

View Other Company Results


Operating Profit
Profit after Tax
Reserves and Surplus
Operating Profit
Profit after Tax

Vijaya Diagnostic Centre Ltd Stocks COMPARISION


Equity Capital: 544.73 Cr FV: 1.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 16,852.71 -20,671.82
LAST 3M 52,922.55 -3,405.64
LAST 6M 58,662.39 139,660.95
LAST 12M 135,235.34 165,245.59

Vijaya Diagnostic Centre Ltd Information

Stock PE (TTM)
Promoter Holding
Book Value
  • Vijaya Diagnostic Centre Limited founded in 1981 by Dr. S. Surendranath Reddy was incorporated as Vijaya Diagnostic Centre Private Limited on 05 June 2002 as a Private Limited Company, which got subsequently, converted to a Public Limited Company and name of the Company was changed to Vijaya Diagnostic Centre Limited on 26 March 2021. The Company is the largest integrated diagnostic chain in South India, providing comprehensive, innovative and best-in-class diagnostic services, in a reliable, affordable and customer-centric manner. The Company is engaged in providing comprehensive range of diagnostic services spanning pathological investigations,basic and high-end radiology,nuclear medicine and related healthcare services. It has a chain of over 95 diagnostic centres spread across 15 cities that offer Laboratory Services, Radiology & Imaging Services, Cardiology Services, Neurology Services & Gastroenterology Services. Apart from these, it serves customers throughout Telangana and Andhra Pradesh with pathology and radiology services. During the FY2020,14,13,071, 0.001% Series A Compulsorily Convertible Preference Shares have been converted into 1 fully paid-up Equity Share of Rs. 10/- each and 3005, 001% Series B Compulsory Convertible Preference Shares have been converted into 3,005 fully paid up Equity Shares of Rs.10/- each. During the year 2020-21,after getting the approval of shareholders at the EGM held on 22 March 2021,the company sub-divided the face value of equity share from Rs 10 to Re 1. On 27 May 2021,the company has issued 5,66,47,736 bonus equity shares of face value Re. 1 each to its shareholders in the ratio of 5:4. The company came out with an Rs 1895.04-crore public issue during the month of September 2021, comprised 35688064 equity shares of Re 1 each at a price of Rs 531 per share.The allotted shares were listed on the BSE Ltd and National Stock Exchange of India Ltd(NSE) on 14 September 2021.

Registered Address

3-6-16&17 Street No.19, Himayatnagar, Hyderabad, Telangana, 500082

Tel : 91-40-23420411
Email : ir:vijayadiagnostic.in
Website : http://www.vijayadiagnostic.com

KFin Techologies Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 543350
Book Closure Date (Month) :
BSE Group : A
ISIN : INE043W01024

FAQ’s on Vijaya Diagnostic Centre Ltd Shares

You can buy Vijaya Diagnostic Centre Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Vijaya Diagnostic Centre Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Oct 04, 2023 12:24 PM the closing price of Vijaya Diagnostic Centre Ltd was ₹ 500.00.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Oct 04, 2023 12:24 PM, the market cap of Vijaya Diagnostic Centre Ltd stood at ₹ 5,105.85.

The latest PE ratio of Vijaya Diagnostic Centre Ltd as of Oct 04, 2023 12:24 PM is 55.47

The latest PB ratio of Vijaya Diagnostic Centre Ltd as of Oct 04, 2023 12:24 PM is 0.11

The 52-week high of Vijaya Diagnostic Centre Ltd is ₹ 529.00 while the 52-week low is ₹ 349.25

Download Our App

market app
market app